As of May 27
| +0.79 / +0.28%|
The 19 analysts offering 12-month price forecasts for Biogen have a median target of 350.00, with a high estimate of 450.00 and a low estimate of 268.00. The median estimate represents a +23.77% increase from the last price of 282.79.
The current consensus among 25 polled investment analysts is to Buy stock in Biogen. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.